These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4114938

  • 1. Localization and properties of an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera.
    Aarli JA.
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(3):453-9. PubMed ID: 4114938
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibodies against nicotinic acetylcholine receptor and skeletal muscle in human and experimental myasthenia gravis.
    Aarli JA, Mattsson C, Heilbronn E.
    Scand J Immunol; 1975; 4(8):849-52. PubMed ID: 1215840
    [Abstract] [Full Text] [Related]

  • 5. [Immunopathology of myasthenia gravis. Comparison of myasthenic sceletal muscle antibodies with rabbit and rat antibodies produced by immunization with skeletal muscle proteins].
    Stroehmann I, Ricken D, Naubereit M, Bruchhausen D.
    Res Exp Med (Berl); 1973 May 21; 160(3):181-95. PubMed ID: 4122532
    [No Abstract] [Full Text] [Related]

  • 6. [Antibodies in the sera of patients with myasthenia gravis].
    Arimori S, Onishi T, Nakata Y.
    Igaku To Seibutsugaku; 1972 Feb 10; 84(2):89-93. PubMed ID: 5065643
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evans blue as counterstain in the demonstration of muscle antibodies by immunofluorescence in myasthenia gravis.
    Closs O, Aarli JA.
    J Clin Pathol; 1974 Feb 10; 27(2):162-7. PubMed ID: 4132968
    [Abstract] [Full Text] [Related]

  • 10. Muscle antibodies in myasthenia gravis.
    Vetters JM.
    Immunology; 1967 Sep 10; 13(3):275-80. PubMed ID: 4861494
    [Abstract] [Full Text] [Related]

  • 11. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE, Aarli JA, Matre R.
    Acta Neurol Scand; 1983 Nov 10; 68(5):328-36. PubMed ID: 6364682
    [Abstract] [Full Text] [Related]

  • 12. Leukocyte response to muscle antigens in myasthenia gravis. Relationship to clinical severity and presence of circulating antibodies.
    Kott E, Genkins G, Rule AH.
    Neurology; 1973 Apr 10; 23(4):374-80. PubMed ID: 4575302
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Myasthenia gravis: cross-striational fluorescence of muscle fibers mediated by Fc fragments.
    Aarli JA, Closs O.
    J Immunol; 1972 Aug 10; 109(2):271-4. PubMed ID: 4558536
    [No Abstract] [Full Text] [Related]

  • 17. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
    Gilhus NE, Aarli JA, Matre R.
    Neurology; 1984 Feb 10; 34(2):246-9. PubMed ID: 6363971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A specific striated muscle antigen of Papio papio monkey (author's transl)].
    Duc HT.
    Z Immunitatsforsch Exp Klin Immunol; 1973 Jun 10; 145(4):293-302. PubMed ID: 4143159
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.